CCNC expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 1.340440E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.661000E-01
Normal-vs-Stage2
9.364100E-02
Normal-vs-Stage3
1.423850E-01
Normal-vs-Stage4
3.602400E-01
Stage1-vs-Stage2
5.837200E-01
Stage1-vs-Stage3
5.318000E-01
Stage1-vs-Stage4
8.197800E-01
Stage2-vs-Stage3
6.315600E-01
Stage2-vs-Stage4
6.060400E-01
Stage3-vs-Stage4
4.323400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
1.270620E-01
Normal-vs-AfricanAmerican
7.385000E-01
Normal-vs-Asian
6.755900E-02
Caucasian-vs-AfricanAmerican
4.817800E-01
Caucasian-vs-Asian
1.976420E-01
AfricanAmerican-vs-Asian
1.678200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
1.278190E-01
Normal-vs-Female
1.612970E-01
Male-vs-Female
4.413400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
1.958610E-01
Normal-vs-Age(41-60Yrs)
3.259000E-01
Normal-vs-Age(61-80Yrs)
5.050100E-02
Normal-vs-Age(81-100Yrs)
4.915600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
4.925800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.723800E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.070200E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.432400E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.693200E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.907400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.839900E-02
Normal-vs-Daily Drinker
8.357900E-03
Normal-vs-Weekly Drinker
1.024250E-01
Normal-vs-Occasional Drinker
4.708000E-01
Normal-vs-Social Drinker
1.023600E-01
Non Drinker-vs-Daily Drinker
5.386300E-02
Non Drinker-vs-Weekly Drinker
9.647200E-01
Non Drinker-vs-Occasional Drinker
1.946400E-01
Non Drinker-vs-Social Drinker
7.955000E-01
Daily Drinker-vs-Weekly Drinker
1.696030E-01
Daily Drinker-vs-Occasional Drinker
2.041900E-02
Daily Drinker-vs-Social Drinker
8.858000E-02
Weekly Drinker-vs-Occasional Drinker
2.749000E-01
Weekly Drinker-vs-Social Drinker
8.233200E-01
Occasional Drinker-vs-Social Drinker
3.377000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
3.348200E-01
Normal-vs-Grade 2
4.323600E-01
Normal-vs-Grade 3
7.678400E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.074800E-01
Grade 1-vs-Grade 3
1.521230E-01
Grade 1-vs-Grade 4
3.348200E-01
Grade 2-vs-Grade 3
8.578400E-01
Grade 2-vs-Grade 4
4.323600E-01
Grade 3-vs-Grade 4
7.678400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.636500E-02
Normal-vs-NonDiabetic
5.154500E-02
Diabetic-vs-NonDiabetic
2.689800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.897800E-03
Normal-vs-NoPancreatitis
6.515800E-02
Pancreatitis-vs-NoPancreatitis
6.127700E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
2.307800E-01
Normal-vs-N1
9.584200E-02
N0-vs-N1
7.134400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.689250E-01
Normal-vs-TP53-NonMutant
5.492400E-01
TP53-Mutant-vs-TP53-NonMutant
7.611900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
